Pediatrix Medical Group (MD) Ratios
Pediatrix Medical Group Ratios
MX:MD's free cash flow for Q3 2026 was $112.93M. For the 2026 fiscal year, MX:MD's free cash flow was decreased by $-4.38M and operating cash flow was $117.31M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 |
| Quick Ratio | 1.66 | 1.47 | 1.24 | 1.00 | 1.97 |
| Cash Ratio | 0.82 | 0.53 | 0.19 | 0.02 | 0.91 |
| Solvency Ratio | 0.14 | -0.05 | -0.02 | 0.07 | 0.09 |
| Operating Cash Flow Ratio | 0.59 | 0.48 | 0.35 | 0.39 | 0.18 |
| Short-Term Operating Cash Flow Coverage | 7.06 | 11.02 | 10.99 | 13.36 | 0.00 |
| Net Current Asset Value | $ -617.33M | $ -748.15M | $ -887.29M | $ -1.03B | $ -985.29M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.29 | 0.31 | 0.32 | 0.31 | 0.39 |
| Debt-to-Equity Ratio | 0.76 | 0.87 | 0.83 | 0.80 | 1.19 |
| Debt-to-Capital Ratio | 0.43 | 0.46 | 0.45 | 0.45 | 0.54 |
| Long-Term Debt-to-Capital Ratio | 0.41 | 0.44 | 0.42 | 0.41 | 0.53 |
| Financial Leverage Ratio | 2.59 | 2.81 | 2.61 | 2.63 | 3.04 |
| Debt Service Coverage Ratio | 3.00 | -0.44 | 0.33 | 2.64 | 3.04 |
| Interest Coverage Ratio | 6.43 | -1.69 | 0.17 | 4.35 | 2.95 |
| Debt to Market Cap | 0.35 | 0.56 | 0.80 | 0.52 | 0.43 |
| Interest Debt Per Share | 8.17 | 8.44 | 8.85 | 9.12 | 13.13 |
| Net Debt to EBITDA | 1.04 | -15.24 | 21.03 | 4.51 | 2.87 |
| Profitability Margins | |||||
| Gross Profit Margin | 24.66% | 22.57% | 21.13% | 23.68% | 26.85% |
| EBIT Margin | 13.19% | -3.01% | -0.32% | 6.14% | 10.67% |
| EBITDA Margin | 14.33% | -1.41% | 1.50% | 7.95% | 12.35% |
| Operating Profit Margin | 12.07% | -3.41% | 0.37% | 8.76% | 10.62% |
| Pretax Profit Margin | 11.31% | -5.03% | -2.42% | 4.13% | 7.08% |
| Net Profit Margin | 8.64% | -4.92% | -3.03% | 3.36% | 6.85% |
| Continuous Operations Profit Margin | 8.64% | -4.92% | -3.03% | 3.17% | 5.65% |
| Net Income Per EBT | 76.42% | 97.76% | 124.92% | 81.52% | 96.85% |
| EBT Per EBIT | 93.66% | 147.48% | -660.55% | 47.12% | 66.64% |
| Return on Assets (ROA) | 7.36% | -4.60% | -2.72% | 2.83% | 4.81% |
| Return on Equity (ROE) | 19.10% | -12.95% | -7.11% | 7.44% | 14.61% |
| Return on Capital Employed (ROCE) | 12.93% | -4.00% | 0.40% | 8.99% | 8.84% |
| Return on Invested Capital (ROIC) | 9.67% | -3.83% | 0.39% | 6.78% | 6.99% |
| Return on Tangible Assets | 17.07% | -11.03% | -7.42% | 8.32% | 10.95% |
| Earnings Yield | 9.07% | -9.06% | -7.73% | 5.38% | 5.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.90 | 7.38 | 7.13 | 6.64 | 6.05 |
| Payables Turnover | 38.74 | 33.57 | 45.48 | 47.24 | 38.15 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 26.04 | 25.66 | 13.67 | 14.06 | 14.09 |
| Asset Turnover | 0.85 | 0.94 | 0.90 | 0.84 | 0.70 |
| Working Capital Turnover Ratio | 7.50 | 13.42 | 41.77 | 9.52 | 2.52 |
| Cash Conversion Cycle | 36.79 | 38.56 | 43.19 | 47.21 | 50.79 |
| Days of Sales Outstanding | 46.21 | 49.43 | 51.21 | 54.93 | 60.35 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 9.42 | 10.87 | 8.03 | 7.73 | 9.57 |
| Operating Cycle | 46.21 | 49.43 | 51.21 | 54.93 | 60.35 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 3.18 | 2.48 | 1.63 | 2.01 | 0.89 |
| Free Cash Flow Per Share | 2.96 | 2.21 | 1.24 | 1.65 | 0.51 |
| Dividend Paid and CapEx Coverage Ratio | 14.69 | 9.38 | 4.12 | 5.62 | 2.38 |
| Capital Expenditure Coverage Ratio | 14.69 | 9.38 | 4.12 | 5.62 | 2.38 |
| Operating Cash Flow Coverage Ratio | 0.41 | 0.31 | 0.20 | 0.23 | 0.07 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.10 | 0.07 | 0.08 | 0.04 |
| Free Cash Flow Yield | 13.85% | 16.88% | 13.31% | 11.13% | 1.89% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 11.03 | -11.03 | -12.93 | 18.58 | 17.96 |
| Price-to-Sales (P/S) Ratio | 0.95 | 0.54 | 0.39 | 0.63 | 1.23 |
| Price-to-Book (P/B) Ratio | 2.11 | 1.43 | 0.92 | 1.38 | 2.62 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 7.22 | 5.92 | 7.51 | 8.98 | 52.86 |
| Price-to-Operating Cash Flow Ratio | 6.73 | 5.29 | 5.69 | 7.38 | 30.64 |
| Price-to-Earnings Growth (PEG) Ratio | -0.04 | -0.17 | 0.07 | -0.39 | -0.15 |
| Enterprise Value Multiple | 7.69 | -53.77 | 47.17 | 12.38 | 12.83 |
| Enterprise Value | 2.11B | 1.53B | 1.41B | 1.94B | 3.03B |
| EV to EBITDA | 7.69 | -53.77 | 47.17 | 12.38 | 12.83 |
| EV to Sales | 1.10 | 0.76 | 0.71 | 0.98 | 1.59 |
| EV to Free Cash Flow | 8.35 | 8.27 | 13.56 | 14.14 | 68.11 |
| EV to Operating Cash Flow | 7.78 | 7.39 | 10.27 | 11.62 | 39.49 |
| Tangible Book Value Per Share | -4.83 | -5.87 | -6.62 | -7.94 | -7.29 |
| Shareholders’ Equity Per Share | 10.15 | 9.18 | 10.11 | 10.75 | 10.37 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.02 | -0.25 | 0.23 | 0.20 |
| Revenue Per Share | 22.45 | 24.16 | 23.74 | 23.77 | 22.11 |
| Net Income Per Share | 1.94 | -1.19 | -0.72 | 0.80 | 1.52 |
| Tax Burden | 0.76 | 0.98 | 1.25 | 0.82 | 0.97 |
| Interest Burden | 0.86 | 1.67 | 7.70 | 0.67 | 0.66 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.12 | 0.11 | 0.12 | 0.14 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 1.64 | -2.09 | -2.27 | 2.67 | 0.71 |
Currency in USD
